Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ TRIM62 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5116643

Catalog No. PIPA5116643


Only null left
Add to Cart

Description

Description

Positive Samples: A-431, Mouse brain Immunogen sequence: HEQHQVTGID DAFDELQREL KDQLQALQDS EREHTEALQL LKRQLAETKS STKSLRTTIG EAFERLHRLL RERQKAMLEE LEADTARTLT DIEQKVQRYS QQLRKVQEGA QILQERLAET DRHTFLAGVA SLSERLKGKI HETNLTYEDF PTSKYTGPLQ Y.

E3 ubiquitin ligase whose activity is dependent on E2 ubiquitin-conjugating enzyme UBE2D2.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

TRIM62
Polyclonal
Unconjugated
TRIM62
6330414G21Rik; AI450348; Dear1; ductal epithelium-associated RING Chromosome 1; E3 ubiquitin-protein ligase TRIM62; RING-type E3 ubiquitin transferase TRIM62; TRIM62; tripartite motif containing 62; tripartite motif-containing 62; tripartite motif-containing protein 62
Rabbit
Affinity chromatography
RUO
313045, 55223, 67525
-20°C, Avoid Freeze/Thaw Cycles
Liquid
ELISA, Immunohistochemistry (Paraffin), Western Blot
0.53 mg/mL
PBS with 50% glycerol and 0.01% thimerosal; pH 7.3
Q80V85, Q9BVG3
TRIM62
Recombinant fusion protein containing a sequence corresponding to amino acids 120-280 of human TRIM62 (NP_0606772).
100 μL
Primary
Human, Mouse, Rat
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.